Cohort (n=55)
No
Answers are grounded in this paper and cite their sources.
Dofetilide is safe and effective for cardioversion and long-term sinus rhythm maintenance in a real-world veteran population with a high burden of comorbidities and baseline ICDs.
Purpose: Data on Dofetilide use in the veteran population remains limited. In clinical trials, Dofetilide has been shown to successfully cardiovert ~30% of atrial fibrillation (AF) patients, while demonstrating variable sinus rhythm (SR) maintenance rates over long-term follow-up. This study investigates Dofetilide therapy in a Veterans Affairs population.
No takes yet. Share an insight, caveat, or question.
Frank Chen (2017) conducted a cohort in Atrial fibrillation, atrial flutter, and ventricular tachycardia (n=55). Dofetilide was evaluated on Incidence of successful cardioversion to sinus rhythm.
Synapse has enriched 10 related papers. Consider them for comparative context: